Christopher Gibson. He's the co-founder and CEO of Recursion Pharmaceuticals, a biotech company leveraging the latest automation, computation and biological tools to perform drug discovery at scale. Chris holds a BS in bioengineering, a BA in managerial studies, and a bioengineering PhD from the University of Utah.

Famous Five:

Favorite Book? – The Hard Thing About Hard Things
What CEO do you follow? – Perry Fell
Favorite online tool? — Slack
Do you get 8 hours of sleep?— 5.3 to 5.4
If you could let your 20-year old self, know one thing, what would it be? – Chris wished he knew where he was going to go so he could get to where he is now, faster

Time Stamped Show Notes:

01:42 – Nathan introduces Chris to the show
02:12 – Recursion shortcuts the long, arduous path of drug discovery into the market
- 02:24 – Recursion combines the best elements of biology, automation, and computation
02:34 – Recursion partners with large pharmaceutical companies
02:45 – Recursion partnered with Sanofi Genzyme
- 02:51 – Sanofi had drugs that didn't end up in the market
03:10 – The challenges involved in being target-based
04:00 – Recursion earns from partnerships and royalties
- 04:20 – Recursion also has an internal pipeline for the drugs that they've developed themselves
- 04:43 – Recursion doesn't earn from the internal pipeline
05:51 – Recursion and what they receive from their partners
- 06:28 – There are partnerships with very, little upfront
- 06:34 – There are partnerships that have 8 figures, upfront
- 06:46 – The number of scientists that will work on the drug is also considered
- 07:22 – If Recursion is successful with their deals, they get royalties
- 08:38 – The royalties' lifeline
08:56 – Recursion has 40 people
09:25 – Recursion was launched in 2013
- 09:34 – They sat in their office until January 2014
10:01 – Chris was part of a program where he was paid a stipend, so he broke even
10:20 – Chris' parents were excited about his PhD
10:37 – Recursion has raised $19M in equity and $5M non-diluted from grants and private foundations
11:28 – Recursion's valuation as a platform company
- 12:14 – If Recursion will be successful, they will impact the society in a big way
- 12:41 – It is vision-based
12:54 – First year revenue was 6 figures
13:12 – "Our deals have been strategic in terms of the way we put them together"
13:45 – 2017 target
16:10 – The Famous Five

3 Key Points:

Different sources of revenue benefit a company.
The valuation of your company depends on how your company is currently performing and how well they will perform in the industry.
First year revenue isn't always nil.

Resources Mentioned:

The Top Inbox – The site Nathan uses to schedule emails to be sent later, set reminders in inbox, track opens, and follow-up with email sequences
Organifi – The juice was Nathan's life saver during his trip in Southeast Asia
Klipfolio – Track your business performance across all departments for FREE
Acuity Scheduling – Nathan uses Acuity to schedule his podcast interviews and appointments
Host Gator – The site Nathan uses to buy his domain names and hosting for the cheapest price possible
Audible – Nathan uses Audible when he's driving from Austin to San Antonio (1.5-hour drive) to listen to audio books
Freshbooks – Nathan doesn't waste time so he uses Freshbooks to send out invoices and collect his money. Get your free month NOW
Show Notes provided by Mallard Creatives

How Can We Whitepill a Blackpilled Gen Z?

The Charlie Kirk Show

Immigration as Gen Z's top issue

The AI-powered Podcast Player